The effect of D-galactosamine on LCAT secretion and ultrastructure of isolated rat hepatocytes.
The effect of D-galactosamine on secretory activity and morphology of isolated rat hepatocytes was investigated: Galactosamine was found to reduce the secretion of lipoproteins (as indicated by the release of free cholesterol and triacylglycerol) as well as the secretion of lecithin: cholesterol acyltransferase (LCAT) and [14C]-labelled proteins from the isolated cells. The secretion of LCAT was inhibited much more than that of the other secretory products studied. Transmission electron microscopy revealed that galactosamine induced morphological changes in RER, mitochondria and nucleoli. The most striking feature of galactosamine-treated hepatocytes, however, was the appearance of swollen lysosomes. Some of these organelles measured up to 3 mumicrometer in diameter. Uridine did not abolish the effect of galactoosamine upon the secretory activity of hepatocytes. The most conspicuous ultrastructural feature in cells that had been incubated with both uridine and galactosamine was the appearance of large amounts of glycogen. The possibility that galactosamine inhibits glycogenolysis is discussed. The rather selective effect of galactosamine on LCAT secretion suggests the use of this compound for the study of the interrelationship between LCAT and lipoprotein secretion.
D000818:Animals; D003593:Cytoplasm / Q000648:ultrastructure; D005688:Galactosamine / Q000494:pharmacology*; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D014529:Uridine / Q000494:pharmacology
D008074:Lipoproteins; D008112:Liver Glycogen; D011506:Proteins; D005688:Galactosamine; D007862:Phosphatidylcholine-Sterol O-Acyltransferase; D014529:Uridine